myelosuppression
Conditions
Interventions
Sponsors
The University Branch of Guangdong Province Hospital of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Patients, between 30 and 70 years of age, diagnosed with ovarian cancer; 2.Patients who have not received chemotherapy and who will undergo TC/TP chemotherapy; 3.Patients who meet the diagnostic criteria of qi deficiency in TCM; 4.Patients who voluntarily sign the informed consent to this trial and consent to participate in all visits as required.
Exclusion criteria
Exclusion criteria: 1.Patients who have hematologic diseases, such as aplastic anemia, acute leukemia, radiation sickness, immune thrombocytopenic purpura, bone marrow invasion of cancers and hypersplenism; 2.Patients who have to use drugs which may cause changes in the blood cells, such as sulfonamides, certain non-steroidal anti-inflammatory drugs; 3.Patients who allergy to multiple drugs; 4.Patients with expected survival time less than 3 months; 5.Patients with serious primary diseases, such as heart, brain, liver and hematopoietic system diseases; 6.Uncooperative patients, such as patients with mental disorder; 7.Patients who are participating in other clinical trials or have participated in other clinical trials within 3 months; 8.Patients have diseases or other conditions that will reduce the possibility of enrollment or complicate the enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| complete blood count; | — |
Secondary
| Measure | Time frame |
|---|---|
| Use of drugs to improve bone marrow hematopoiesis;TCM Syndrome; | — |
Countries
China
Contacts
Public ContactJing Xiao
The Second clinical college of Guangzhou University of Chinese Medicine
Outcome results
None listed